For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Deucravacitinib Treatment for Lichen Planopilaris | Subjects diagnosed with Lichen Planopilaris (LP) received Deucravacitinib for 24 weeks. Deucravacitinib: 6 milligram (mg) orally administrated, twice daily | 0 | None | 1 | 11 | 11 | 11 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Diverticulitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Rash on Neck | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Sore Throat/Lymph Nodes | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hair Loss | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Mouth Sore | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Acne | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hand Dermatitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash/Acne | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Virus (cold/flu) | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Bakers Cyst | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Canker Sore and Mouth Tenderness | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Canker Sores on Tongue | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Upper Respiratory Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gastrointestinal Pain after starting Protopic | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Inflammation of Gingiva | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mouth Burning | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mouth Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pain in Right Ear | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |